Legend: drug field target field enzyme field
| Version | 2.5 |
| Creation Date | 2007-07-08 17:05:14 |
| Update Date | 2009-06-23 18:06:16 |
| Primary Accession Number | DB01398 |
| Secondary Accession Number | Not Available |
| Name | Salicylate-sodium |
| Drug Type |
|
| Description | Sodium salicylate is a sodium salt of salicylic acid. It can be prepared from sodium phenolate and carbon dioxide under higher temperature and pressure. It is used in medicine as an analgesic and antipyretic. Sodium salicylate also acts as non-steroidal anti-inflammatory drug (NSAID) and induces apoptosis in cancer cells. It is also potential replacement for aspirin for people sensitive to it. |
| Synonyms | Not Available |
| Brand Names | Not Available |
| Brand Mixtures | Not Available |
| Chemical IUPAC Name | Not Available |
| Chemical Formula | Not Available |
| Chemical Structure | |
| CAS Registry Number | Not Available |
| InChI Identifier | Not Available |
| InChI Key | Not Available |
| KEGG Drug | Not Available |
| KEGG Compound | Not Available |
| PubChem Compound | Not Available |
| PubChem Substance | Not Available |
| ChEBI ID | Not Available |
| PharmGKB ID | Not Available |
| HET ID | Not Available |
| GenBank ID | Not Available |
| Drug ID Number [DIN] | Not Available |
| RxList Link | Not Available |
| PDRhealth Link | Not Available |
| Wikipedia Link | http://en.wikipedia.org/wiki/Sodium_salicylate ![]() |
| FDA Label | Not Available |
| Material Safety Data Sheet (MSDS) | Not Available |
| Synthesis Reference | Not Available |
| Average Molecular Weight | Not Available |
| Monoisotopic Molecular Weight | Not Available |
| State | Solid |
| Melting Point | Not Available |
| Experimental Water Solubility | Not Available Source: PhysProp |
| Predicted Water Solubility | Not Available Calculated using ALOGPS |
| Experimental LogP/Hydrophobicity | Not Available Source: PhysProp |
| Predicted LogP | Not Available Calculated using ALOGPS |
| Experimental LogS | Not Available |
| Predicted LogS | Not Available Calculated using ALOGPS |
| Experimental Caco2 Permeability | Not Available |
| pKa/Isoelectric Point | Not Available |
| Mass Spectrum | Not Available |
| MOL File | Not Available |
| SDF File | Not Available |
| PDB File | Not Available |
| Experimental PDB ID | Not Available |
| Isomeric SMILES | Not Available |
| Canonical SMILES | Not Available |
| Drug Category | Not Available |
| ATC Codes | Not Available |
| AHFS Codes | Not Available |
| Indication | Not Available |
| Pharmacology | Not Available |
| Mechanism of Action | Not Available |
| Absorption | Not Available |
| Toxicity | Not Available |
| Protein Binding | Not Available |
| Biotransformation | Not Available |
| Half Life | Not Available |
| Dosage Forms | Not Available |
| Patient Information | Not Available |
| Contraindications | Not Available |
| Interactions | Not Available |
| Drug Interactions | Not Available |
| Food Interactions | Not Available |
| Pathways | Not Available |
| General References | |
| Organisms Affected | Not Available |
This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.